Catherine Farrokhi

811 total citations
18 papers, 660 citations indexed

About

Catherine Farrokhi is a scholar working on Molecular Biology, Genetics and Behavioral Neuroscience. According to data from OpenAlex, Catherine Farrokhi has authored 18 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Genetics and 5 papers in Behavioral Neuroscience. Recurrent topics in Catherine Farrokhi's work include Stress Responses and Cortisol (5 papers), Virus-based gene therapy research (5 papers) and RNA Interference and Gene Delivery (4 papers). Catherine Farrokhi is often cited by papers focused on Stress Responses and Cortisol (5 papers), Virus-based gene therapy research (5 papers) and RNA Interference and Gene Delivery (4 papers). Catherine Farrokhi collaborates with scholars based in United States, France and Germany. Catherine Farrokhi's co-authors include Pamela Maher, Richard Dargusch, António Currais, David Schubert, Robert J. Blanchard, D. Caroline Blanchard, Robert N. Pechnick, Aaron M. Armando, Oswald Quehenberger and Mu Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Virology.

In The Last Decade

Catherine Farrokhi

18 papers receiving 646 citations

Peers

Catherine Farrokhi

PHYSI

GENET

Wenyu Cao China

Søren H. Christiansen Denmark

Ryoichi Banno Japan

Thomas Wultsch Austria

Hikaru Ito Japan

Yuyan Cheng United States

Takeshi Hiramoto Japan

Bertalan Dudás United States

Krzysztof Lyson United States

James W. McBlane United Kingdom

Wenyu Cao China

Catherine Farrokhi

311 ×1.3

75 ×0.5

PHYSI

54 ×0.4

GENET

80 ×0.7

166 ×1.4

Citations per year, relative to Catherine Farrokhi Catherine Farrokhi (= 1×) peers Wenyu Cao

Countries citing papers authored by Catherine Farrokhi

Since Specialization

Citations

This map shows the geographic impact of Catherine Farrokhi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Farrokhi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Farrokhi more than expected).

Fields of papers citing papers by Catherine Farrokhi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Farrokhi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Farrokhi. The network helps show where Catherine Farrokhi may publish in the future.

Co-authorship network of co-authors of Catherine Farrokhi

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Farrokhi. A scholar is included among the top collaborators of Catherine Farrokhi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Farrokhi. Catherine Farrokhi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Currais, António, Catherine Farrokhi, Richard Dargusch, et al.. (2017). Fisetin Reduces the Impact of Aging on Behavior and Physiology in the Rapidly Aging SAMP8 Mouse. The Journals of Gerontology Series A. 73(3). 299–307. 107 indexed citations

Winter, Fred de, Catherine Farrokhi, Edward Rockenstein, et al.. (2016). Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer’s disease model. Scientific Reports. 6(1). 31692–31692. 43 indexed citations

Prior, Marguerite, Joshua Goldberg, Chandramouli Chiruta, et al.. (2016). Selecting for neurogenic potential as an alternative for Alzheimer's disease drug discovery. Alzheimer s & Dementia. 12(6). 678–686. 31 indexed citations

Currais, António, et al.. (2015). Dietary glycemic index modulates the behavioral and biochemical abnormalities associated with autism spectrum disorder. Molecular Psychiatry. 21(3). 426–436. 32 indexed citations

Currais, António, Joshua Goldberg, Catherine Farrokhi, et al.. (2015). A comprehensive multiomics approach toward understanding the relationship between aging and dementia. Aging. 7(11). 937–955. 68 indexed citations

Puntel, Mariana, Catherine Farrokhi, Kurt M. Kroeger, et al.. (2013). Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastoma. Toxicology and Applied Pharmacology. 268(3). 318–330. 18 indexed citations

Muhammad, A.K.M. Ghulam, Weidong Xiong, Mariana Puntel, et al.. (2012). Safety Profile of Gutless Adenovirus Vectors Delivered into the Normal Brain Parenchyma: Implications for a Glioma Phase 1 Clinical Trial. Human Gene Therapy Methods. 23(4). 271–284. 19 indexed citations

Pechnick, Robert N., et al.. (2011). Acamprosate attenuates cue-induced reinstatement of nicotine-seeking behavior in rats. Behavioural Pharmacology. 22(3). 222–227. 6 indexed citations

Pechnick, Robert N., et al.. (2011). Antidepressants Stimulate Hippocampal Neurogenesis by Inhibiting p21 Expression in the Subgranular Zone of the Hipppocampus. PLoS ONE. 6(11). e27290–e27290. 65 indexed citations

10.

Muhammad, A.K.M. Ghulam, Mariana Puntel, Marianela Candolfi, et al.. (2010). Study of the Efficacy, Biodistribution, and Safety Profile of Therapeutic Gutless Adenovirus Vectors as a Prelude to a Phase I Clinical Trial for Glioblastoma. Clinical Pharmacology & Therapeutics. 88(2). 204–213. 32 indexed citations

11.

Puntel, Mariana, A.K.M. Ghulam Muhammad, Marianela Candolfi, et al.. (2010). A Novel Bicistronic High-Capacity Gutless Adenovirus Vector That Drives Constitutive Expression of Herpes Simplex Virus Type 1 Thymidine Kinase and Tet-Inducible Expression of Flt3L for Glioma Therapeutics. Journal of Virology. 84(12). 6007–6017. 34 indexed citations

12.

Larocque, Daniel, Nicholas Sanderson, Josée Bergeron, et al.. (2010). Exogenous fms-like tyrosine kinase 3 ligand overrides brain immune privilege and facilitates recognition of a neo-antigen without causing autoimmune neuropathology. Proceedings of the National Academy of Sciences. 107(32). 14443–14448. 17 indexed citations

13.

Candolfi, Marianela, Kurt M. Kroeger, Kader Yagiz, et al.. (2009). Gene Therapy for Brain Cancer: Combination Therapies Provide Enhanced Efficacy and Safety. Current Gene Therapy. 9(5). 409–421. 37 indexed citations

14.

Tovote, Philip, Catherine Farrokhi, Udo Schnitzbauer, et al.. (2009). Activation of central CRF receptor 1 by cortagine results in enhanced passive coping with a naturalistic threat in mice. Psychoneuroendocrinology. 35(6). 887–895. 9 indexed citations

15.

Farrokhi, Catherine, Philip Tovote, Robert J. Blanchard, et al.. (2007). Cortagine: Behavioral and Autonomic Function of the Selective CRF Receptor Subtype 1 Agonist. CNS Drug Reviews. 13(4). 423–443. 22 indexed citations

16.

Yang, Mu, et al.. (2006). Central infusion of ovine CRF (oCRF) potentiates defensive behaviors in CD-1 mice in the Mouse Defense Test Battery (MDTB). Behavioural Brain Research. 171(1). 1–8. 14 indexed citations

17.

Farrokhi, Catherine, D. Caroline Blanchard, Guy Griebel, et al.. (2004). Effects of the CRF1 antagonist SSR125543A on aggressive behaviors in hamsters. Pharmacology Biochemistry and Behavior. 77(3). 465–469. 32 indexed citations

18.

Blanchard, Robert J., Guy Griebel, Catherine Farrokhi, et al.. (2004). AVP V selective antagonist SSR149415 blocks aggressive behaviors in hamsters. Pharmacology Biochemistry and Behavior. 80(1). 189–194. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact